Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil

Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil

The rapid development of efficacious and safe vaccines against coronavirus disease 2019 (COVID-19) has been instrumental in mitigating the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, the emergence of SARS-CoV-2 variants raised concerns on the efficacy of t...

Full description

Bibliographic Details
Main Authors: Cassia F. Estofolete, Cecilia A. Banho, Guilherme R. F. Campos, Beatriz de C. Marques, Livia Sacchetto, Leila S. Ullmann, Fabio S. Possebon, Luana F. Machado, Juliana D. Syrio, João P. Araújo Junior, Cintia Bittar, Paula Rahal, Suzana M. A. Lobo, Helena Lage Ferreira, Nikos Vasilakis, Mauricio L. Nogueira
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Viruses
Subjects:
SARS-CoV-2
COVID-19
vaccine
Online Access:https://www.mdpi.com/1999-4915/13/7/1237

Internet

https://www.mdpi.com/1999-4915/13/7/1237

Similar Items